Mylan (United States)

Recent papers from Mylan (United States)

1. A randomized, double-blind, placebo-controlled, parallel group, dose-response study of MR-107A-02 in the treatment of post-surgical dental painPain Medicine · 2026
2. B24-11 Exacerbation Outcomes With Revefenacin in COPD Patients With Cardiovascular Risk or History: Exploratory Analyses From Study 0128American Journal of Respiratory and Critical Care Medicine · 2026
3. B24-10 Earlier Onset of Bronchodilation With Revefenacin: New Analyses From Phase 3 COPD TrialsAmerican Journal of Respiratory and Critical Care Medicine · 2026
4. GD2 Identifies Cancer Stemness in Glioblastoma and Phytoalexin Library Screen Identifies Potential Novel Natural InhibitorsInternational Journal of Molecular Sciences · 2026
5. Patient Preferences for COPD Maintenance Therapies in the United StatesRespiratory Care · 2024
6. A concise review on nanoscale carriers to target intracellular infectionsSHILAP Revista de lepidopterología · 2026
7. Safety Outcomes from a Long-Term, Prospective Study of Sertraline Use in Children and Adolescents: The Sertraline Pediatric Registry for the Evaluation of SafetyJournal of Child and Adolescent Psychopharmacology · 2025
8. Development and validation of a novel simultaneous equation and Q-absorbance ratio method for the quantitative estimation of atenolol and hydrochlorothiazide in combined tablet dosage forms: A green analytical chemistry approachGreen Analytical Chemistry · 2025
9. Determination of the Bioavailability of 3 Intranasal Formulations of Azelastine Hydrochloride in Healthy Male VolunteersClinical Pharmacology in Drug Development · 2025
10. Implementing numerical algorithms to optimize the parameters in Kampmann–Wagner Numerical (KWN) precipitation modelsnpj Computational Materials · 2024
11. Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complexExpert Review of Anti-infective Therapy · 2024
12. Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I studyScientific Reports · 2024
13. Prevalence and Management of Chronic Obstructive Pulmonary Disease in the Gulf Countries with a Focus on Inhaled PharmacotherapyJournal of Aerosol Medicine and Pulmonary Drug Delivery · 2024
14. The Comparative Bioavailability of Fluticasone and Azelastine Delivered as a Single Fixed Dose Combination (MP-AzeFlu) in Comparison to Two Different Formulations of Azelastine and Fluticasone Propionate Following Intranasal Administration in Healthy Chinese VolunteersJournal of Asthma and Allergy · 2023
15. Enhanced Patient-Centricity: How the Biopharmaceutical Industry Is Optimizing Patient Care through AI/ML/DLHealthcare · 2022
16. Considerations for Conducting Bring Your Own “Device” (BYOD) Clinical StudiesDigital Biomarkers · 2022
17. Americans' Awareness of Access Changes and Utilization of Telehealth During COVID-19: A Survey in the United StatesTelemedicine Journal and e-Health · 2022
18. MAP3K Family Review and Correlations with Patient Survival Outcomes in Various Cancer TypesFrontiers in Bioscience-Landmark · 2022
19. Prevalence, Comorbidities, and Risk Factors of Erectile Dysfunction: Results from a Prospective Real‐World Study in the United KingdomInternational Journal of Clinical Practice · 2022
20. Chrysin Ameliorates Cyclosporine-A-Induced Renal Fibrosis by Inhibiting TGF-β1-Induced Epithelial–Mesenchymal TransitionInternational Journal of Molecular Sciences · 2021